| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Issues Articles
Glucose-controlling metformin, the generic drug that is the first medication that many newly diagnosed type 2s take, could soon be available in a chewing gum.
Glucose-controlling metformin, the generic drug that is the first medication for many newly diagnosed type 2s, could soon be available in a chewing gum.
That’s the hope held by Massachusetts-based Generex Biotechnology Corporation, which has announced that it is ready to test its proprietary metformin chewing gum product, MetControl™, on 36 volunteer patients. In the study, Generex will compare the speed and efficacy of MetControl to that of immediate-release metformin tablets.
Metformin is the most prescribed drug for type 2 patients. Nevertheless, many people with diabetes avoid using it because of its gastrointestinal side effects, large pill size and bitter taste. These factors are especially off-putting to the increasing number of children being diagnosed with type 2.
Generex believes that the delivery of metformin in a good-tasting chewing gum will make the drug more acceptable to these patients and thereby increase adherence with diabetes therapy.
Because metformin is safe, well known and well established, the company does not anticipate taking as long to come to market with MetControl as it would with a product containing a new active compound. Such products typically must undergo stringent testing that can last years.
Categories: Type 2 Issues, Type 2 Medications
May 15, 2008 -
Email to a Friend
Send a link to this page to your friends and colleagues.